OCALIVA  NCT02548351


Laboratory : Intercept Pharma

Study Name : REGENERATE

Phase 3

Study Number : NCT02548351

Number of patients recruited : 2000

Probability to be under placebo : 33%

Contacts : 

Contact: Szecho Lin, B.S. (858) 832 4509

szecho.lin@interceptpharma.com


DEDICATED WEB SITE HERE













Share on StockTwits

WWW.NASHBIOTECHS.COM  -  Copyright G DIVRY 2015-2016  - Contact and TERMS OF USE